ClinicalTrials.Veeva

Menu

Proposal to Evaluate the Efficacy of the InterX 5000 in the Treatment of Chronic Neck and Shoulder Pain

H

Hamilton Health Sciences (HHS)

Status and phase

Completed
Phase 2

Conditions

Shoulder Pain
Cervical Pain
Neck Pain

Treatments

Device: InterX 5000 Treatment
Device: Inactive InterX 5000

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The purpose of the proposed study is to evaluate the efficacy of the InterX 5000 in relieving chronic neck and shoulder pain. This study will focus on the efficacy of treating patients who have functional limitations in activity because of chronic/recurrent neck or shoulder pain.

H1: InterX therapy will have a moderate effect to reduce pain.

H2: Functional gains will be greater in patients receiving InterX therapy compared to those who received placebo treatment.

H3: Chronic neck and shoulder pain is more prevalent in patients who exhibit radiographic evidence of degenerative spondylosis/arthrosis of the cervical spine.

Full description

Electrical stimulation modalities of various types have been used as a therapeutic intervention for years in a wide variety of applications. Individuals with neck and shoulder pain represent a significant segment of the pain population seeking relief. However, there is a paucity of data from quality studies published in mainstream peer-reviewed journals supporting the effectiveness of this intervention. No well-designed prospective, randomized, controlled trials investigating the efficacy or effectiveness of this intervention in patients with chronic neck and shoulder pain have been reported. The need for such work is becoming increasingly important considering the progressively greater demands for evidence-based medicine to justify reimbursement for care.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 66 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • chronic or recurrent neck or shoulder pain of at least 3 months duration with or without arm pain
  • willing to sign consent for study participation
  • able/willing to comply with treatment schedule

Exclusion criteria

  • clinically significant herniated disc (defined as positive radicular arm pain aggravated by head position change or neural stretch signs from provocative arm movement, this will not exclude patients with any imaged herniation as this is a common finding in all populations)
  • spinal fracture
  • previous electrical stimulation treatment for this episode
  • recent cervical spinal or shoulder surgery or implanted instrumentation/prostheses.
  • patients with cardiac pacemaker or spinal cord stimulator, epilepsy, pregnancy, recent (3 months) chemotherapy/radiotherapy, phlebitis, cortisone use (30 days)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

80 participants in 2 patient groups, including a placebo group

1
Active Comparator group
Description:
InterX treatment plus rehabilitation exercises
Treatment:
Device: InterX 5000 Treatment
2
Placebo Comparator group
Description:
Inactive InterX treatment plus rehabilitation exercises
Treatment:
Device: Inactive InterX 5000

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems